Recently, single nucleotide polymorphisms (SNPs) in low-penetrance genes, such as ESR1, TOX3, and FGFR2, have been shown to modify the risk of developing breast cancer in a large series of 413 Italian MBCs [21]. This evidence concerns the gene ESR1 and breast carcinoma.